Bacterial composition and its use
View Patent ↗The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801 and Bifidobacterium lactis PTA-4802. An other subject of the invention is an immunomodulation method comprising the step of using the at least one strain selected from the preceding group.
1. A bacterial composition having immunomodulation properties comprising Bifidobacterium lactis PTA-4802.
2. The bacterial composition according to claim 1 further comprising at least one additional strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, and Bifidobacterium bifidum PTA-4801.
3. The bacterial composition according to claim 1 further comprising at least two additional strains selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, and Bifidobacterium bifidum PTA-4801.
4. The bacterial composition according to claim 1 comprising a blend of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium lactis PTA-4802, and Bifidobacterium bifidum PTA-4801.
5. The bacterial composition according to claim 1 , comprising from 10 5 to 10 11 CFU of bactena/g of composition.
6. The bacterial composition according to claim 5 , comprising from 10 8 to 10 11 CFU of bactenalg of composition.
7. A process for the prevention or the reduction of inflammatory bowel disease, comprising the step of administering to a human or an animal an efficient preventing or reducing amount of inflammatory bowel disease, of a bacterial composition as defined in claim 1 .
8. A process for maintaining the homeostatis of the immune system comprising the step of administering to a human or an animal an efficient maintaining amount of the homeostasis of the immune system, of a bacterial composition as defined in claim 1 .
9. A process for the prevention or the reduction of allergenicity comprising the step of administering to a human or an animal an efficient preventing or reducing amount of allergenicity, of a bacterial composition as defined in claim 1 .
10. An immunoadjuvent composition, comprising a bacterial composition as defined in claim 1 .
11. An immunomodulation method comprising the step of using Bifidobacterium lactis PTA-4802.
12. A food, dietary supplement or pharmaceutical composition comprising a composition as defined in claim 1 .
13. The composition according to claim 12 , being in the form of a dairy product.
14. The composition according to claim 13 , being in the form of an infant formula.
15. The composition according to claim 13 , having immunomodulation properties.
16. A pharmaceutical composition comprising the composition as defined in claim 1 for the prevention of inflammatory bowel disease.
17. A pharmaceutical composition comprising the composition as defined in claim 1 for immunomodulation.
18. The immunomodulation method according to claim 11 , further comprising using at least one additional strain selected from the group consisting of Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, and Bifidobacterium bifidum PTA-4801.